lag 3 pe Search Results


rea351  (Miltenyi Biotec)
93
Miltenyi Biotec rea351
Immunophenotyping panel for multiplexed tissue imaging of cancer.
Rea351, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rea351/product/Miltenyi Biotec
Average 93 stars, based on 1 article reviews
rea351 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
mouse anti lag3 antibodies  (Sino Biological)
92
Sino Biological mouse anti lag3 antibodies
Immunophenotyping panel for multiplexed tissue imaging of cancer.
Mouse Anti Lag3 Antibodies, supplied by Sino Biological, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti lag3 antibodies/product/Sino Biological
Average 92 stars, based on 1 article reviews
mouse anti lag3 antibodies - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier
phycoerythrin pe lag 3  (R&D Systems)
96
R&D Systems phycoerythrin pe lag 3
Immunophenotyping panel for multiplexed tissue imaging of cancer.
Phycoerythrin Pe Lag 3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phycoerythrin pe lag 3/product/R&D Systems
Average 96 stars, based on 1 article reviews
phycoerythrin pe lag 3 - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier
lag 3 pe  (R&D Systems)
93
R&D Systems lag 3 pe
Immunophenotyping panel for multiplexed tissue imaging of cancer.
Lag 3 Pe, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lag 3 pe/product/R&D Systems
Average 93 stars, based on 1 article reviews
lag 3 pe - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
lag 3 pe  (R&D Systems Hematology)
90
R&D Systems Hematology lag 3 pe
Immunophenotyping panel for multiplexed tissue imaging of cancer.
Lag 3 Pe, supplied by R&D Systems Hematology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lag 3 pe/product/R&D Systems Hematology
Average 90 stars, based on 1 article reviews
lag 3 pe - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
lag 3  (R&D Systems Hematology)
92
R&D Systems Hematology lag 3
Immunophenotyping panel for multiplexed tissue imaging of cancer.
Lag 3, supplied by R&D Systems Hematology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lag 3/product/R&D Systems Hematology
Average 92 stars, based on 1 article reviews
lag 3 - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier
lag3  (Novus Biologicals)
90
Novus Biologicals lag3
Figure 1. Expression of IC by CD3+ TILs from CRC tumors according to the microsatellite status. For each figure, data were analyzed according to the MSS/MSI status, with MSS tumors shown in pale green and MSI tumors in dark blue. (A) Representative histograms showing the expression of PD-1, TIGIT, Tim-3, <t>Lag3</t> and NKG2A on CD3+ TILs from an MSS patient (upper panels) or from an MSI patient (lower panels). Results were expressed as positive cells and median fluorescence intensity (MFI). Isotypic controls are overlaid in grey. (B) Frequency of PD-1+, TIGIT+, Tim-3+, Lag3+
Lag3, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lag3/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
lag3 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
cd223 antibody  (Miltenyi Biotec)
93
Miltenyi Biotec cd223 antibody
Figure 1. Expression of IC by CD3+ TILs from CRC tumors according to the microsatellite status. For each figure, data were analyzed according to the MSS/MSI status, with MSS tumors shown in pale green and MSI tumors in dark blue. (A) Representative histograms showing the expression of PD-1, TIGIT, Tim-3, <t>Lag3</t> and NKG2A on CD3+ TILs from an MSS patient (upper panels) or from an MSI patient (lower panels). Results were expressed as positive cells and median fluorescence intensity (MFI). Isotypic controls are overlaid in grey. (B) Frequency of PD-1+, TIGIT+, Tim-3+, Lag3+
Cd223 Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd223 antibody/product/Miltenyi Biotec
Average 93 stars, based on 1 article reviews
cd223 antibody - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
mabs lag 3  (Miltenyi Biotec)
93
Miltenyi Biotec mabs lag 3
Figure 1. Expression of IC by CD3+ TILs from CRC tumors according to the microsatellite status. For each figure, data were analyzed according to the MSS/MSI status, with MSS tumors shown in pale green and MSI tumors in dark blue. (A) Representative histograms showing the expression of PD-1, TIGIT, Tim-3, <t>Lag3</t> and NKG2A on CD3+ TILs from an MSS patient (upper panels) or from an MSI patient (lower panels). Results were expressed as positive cells and median fluorescence intensity (MFI). Isotypic controls are overlaid in grey. (B) Frequency of PD-1+, TIGIT+, Tim-3+, Lag3+
Mabs Lag 3, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mabs lag 3/product/Miltenyi Biotec
Average 93 stars, based on 1 article reviews
mabs lag 3 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
anti mouse lag3 pe  (Miltenyi Biotec)
92
Miltenyi Biotec anti mouse lag3 pe
Figure 1. Expression of IC by CD3+ TILs from CRC tumors according to the microsatellite status. For each figure, data were analyzed according to the MSS/MSI status, with MSS tumors shown in pale green and MSI tumors in dark blue. (A) Representative histograms showing the expression of PD-1, TIGIT, Tim-3, <t>Lag3</t> and NKG2A on CD3+ TILs from an MSS patient (upper panels) or from an MSI patient (lower panels). Results were expressed as positive cells and median fluorescence intensity (MFI). Isotypic controls are overlaid in grey. (B) Frequency of PD-1+, TIGIT+, Tim-3+, Lag3+
Anti Mouse Lag3 Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse lag3 pe/product/Miltenyi Biotec
Average 92 stars, based on 1 article reviews
anti mouse lag3 pe - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier
anti human lag  (BPS Bioscience)
93
BPS Bioscience anti human lag
Figure 1. Expression of IC by CD3+ TILs from CRC tumors according to the microsatellite status. For each figure, data were analyzed according to the MSS/MSI status, with MSS tumors shown in pale green and MSI tumors in dark blue. (A) Representative histograms showing the expression of PD-1, TIGIT, Tim-3, <t>Lag3</t> and NKG2A on CD3+ TILs from an MSS patient (upper panels) or from an MSI patient (lower panels). Results were expressed as positive cells and median fluorescence intensity (MFI). Isotypic controls are overlaid in grey. (B) Frequency of PD-1+, TIGIT+, Tim-3+, Lag3+
Anti Human Lag, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human lag/product/BPS Bioscience
Average 93 stars, based on 1 article reviews
anti human lag - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
lag 3  (BPS Bioscience)
93
BPS Bioscience lag 3
Figure 1. Expression of IC by CD3+ TILs from CRC tumors according to the microsatellite status. For each figure, data were analyzed according to the MSS/MSI status, with MSS tumors shown in pale green and MSI tumors in dark blue. (A) Representative histograms showing the expression of PD-1, TIGIT, Tim-3, <t>Lag3</t> and NKG2A on CD3+ TILs from an MSS patient (upper panels) or from an MSI patient (lower panels). Results were expressed as positive cells and median fluorescence intensity (MFI). Isotypic controls are overlaid in grey. (B) Frequency of PD-1+, TIGIT+, Tim-3+, Lag3+
Lag 3, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lag 3/product/BPS Bioscience
Average 93 stars, based on 1 article reviews
lag 3 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

Image Search Results


Immunophenotyping panel for multiplexed tissue imaging of cancer.

Journal: Frontiers in Immunology

Article Title: Unveiling spatial complexity in solid tumor immune microenvironments through multiplexed imaging

doi: 10.3389/fimmu.2024.1383932

Figure Lengend Snippet: Immunophenotyping panel for multiplexed tissue imaging of cancer.

Article Snippet: LAG3 , REA351 , 25 , 130-120-470 , PE , Miltenyi Biotec.

Techniques: Imaging

Figure 1. Expression of IC by CD3+ TILs from CRC tumors according to the microsatellite status. For each figure, data were analyzed according to the MSS/MSI status, with MSS tumors shown in pale green and MSI tumors in dark blue. (A) Representative histograms showing the expression of PD-1, TIGIT, Tim-3, Lag3 and NKG2A on CD3+ TILs from an MSS patient (upper panels) or from an MSI patient (lower panels). Results were expressed as positive cells and median fluorescence intensity (MFI). Isotypic controls are overlaid in grey. (B) Frequency of PD-1+, TIGIT+, Tim-3+, Lag3+

Journal: Cancers

Article Title: Defining the Immune Checkpoint Landscape in Human Colorectal Cancer Highlights the Relevance of the TIGIT/CD155 Axis for Optimizing Immunotherapy.

doi: 10.3390/cancers14174261

Figure Lengend Snippet: Figure 1. Expression of IC by CD3+ TILs from CRC tumors according to the microsatellite status. For each figure, data were analyzed according to the MSS/MSI status, with MSS tumors shown in pale green and MSI tumors in dark blue. (A) Representative histograms showing the expression of PD-1, TIGIT, Tim-3, Lag3 and NKG2A on CD3+ TILs from an MSS patient (upper panels) or from an MSI patient (lower panels). Results were expressed as positive cells and median fluorescence intensity (MFI). Isotypic controls are overlaid in grey. (B) Frequency of PD-1+, TIGIT+, Tim-3+, Lag3+

Article Snippet: The following primary antibodies were used: CD3 (Agilent Technologies, polyclonal rabbit anti-human, RRID:AB_2335677), CD8 (Agilent Technologies, monoclonal mouse anti-human clone C8/144B, RRID:AB_2075537), PD-1 (Abcam, Cambridge, UK, monoclonal mouse antihuman clone NAT105, RRID:AB_881954), TIGIT (Cell Signaling Technology, Danvers, MA, USA; monoclonal rabbit anti-human clone ESY1W, RRID:AB_2922806), Tim-3 (Bio-Techne, Minneaoplis, MN, USA, polyclonal goat anti-human, RRID:AB_355235), Lag3 (Novus, BioTechne, monoclonal mouse anti-human clone 17B4, RRID:AB_11162489), CD94 (Diaclone, Besançon, France; monoclonal mouse anti-human clone B-D49, RRID:AB_2922808), PD-L1 Cancers 2022, 14, 4261 5 of 21 (Programmed death-ligand 1) (Cell Signaling Technology, monoclonal rabbit anti-human clone E1L3N, RRID:AB_2687655), CD155 (Cell Signaling Technology, monoclonal mouse anti-human clone D8A5G, RRID:AB_2799970), galectin-9 (Abcam, polyclonal rabbit antihuman, RRID:AB_1268942), HLA-DR (Abcam, monoclonal mouse anti-human clone SPM289, RRID:AB_444051) and HLA-E (Bio-Rad, Marnes-la-Coquette, France; monoclonal mouse anti-human clone MEM-E/02, RRID:AB_324025).

Techniques: Expressing

Figure 3. Identification of 14 CD8+ TIL clusters based on differential expression of ICs. (A) FlowSOM tree of CD8+ TILs from cohort 2 tumors (n = 20). The background coloring represents meta-clustering and the legends of the star plot and meta-clustering are shown on the right side. (B) Heatmap of the MFI of the PD-1, TIGIT, Tim-3, Lag3 and NKG2A markers expressed, or not expressed, by the 14 clusters identified in the CD8+ TIL population generated from cohort 2 tumors (n = 20). (C) Cell frequency in each CD4+ TIL cluster generated from cohort 2 tumors (n = 20). (D) Cell frequency in each CD4+ TIL cluster generated from cohort 2 and 3 tumors (n = 32) according to the MSS/MSI status (pale green and dark blue, respectively). The clusters of the two cohorts were merged and the cluster numbering from cohort 2 was retained; Mann–Whitney tests. (E) Principal component analysis of tumors from cohorts 2 and 3 based on cell frequencies in each generated CD8+ TIL cluster, with MSS tumors are in pale green triangles and MSI tumors in dark blue circles. Ellipses were drawn to highlight two new groups of colorectal tumors: the IChigh group (in dark blue) and the IClow group (in pale green).

Journal: Cancers

Article Title: Defining the Immune Checkpoint Landscape in Human Colorectal Cancer Highlights the Relevance of the TIGIT/CD155 Axis for Optimizing Immunotherapy.

doi: 10.3390/cancers14174261

Figure Lengend Snippet: Figure 3. Identification of 14 CD8+ TIL clusters based on differential expression of ICs. (A) FlowSOM tree of CD8+ TILs from cohort 2 tumors (n = 20). The background coloring represents meta-clustering and the legends of the star plot and meta-clustering are shown on the right side. (B) Heatmap of the MFI of the PD-1, TIGIT, Tim-3, Lag3 and NKG2A markers expressed, or not expressed, by the 14 clusters identified in the CD8+ TIL population generated from cohort 2 tumors (n = 20). (C) Cell frequency in each CD4+ TIL cluster generated from cohort 2 tumors (n = 20). (D) Cell frequency in each CD4+ TIL cluster generated from cohort 2 and 3 tumors (n = 32) according to the MSS/MSI status (pale green and dark blue, respectively). The clusters of the two cohorts were merged and the cluster numbering from cohort 2 was retained; Mann–Whitney tests. (E) Principal component analysis of tumors from cohorts 2 and 3 based on cell frequencies in each generated CD8+ TIL cluster, with MSS tumors are in pale green triangles and MSI tumors in dark blue circles. Ellipses were drawn to highlight two new groups of colorectal tumors: the IChigh group (in dark blue) and the IClow group (in pale green).

Article Snippet: The following primary antibodies were used: CD3 (Agilent Technologies, polyclonal rabbit anti-human, RRID:AB_2335677), CD8 (Agilent Technologies, monoclonal mouse anti-human clone C8/144B, RRID:AB_2075537), PD-1 (Abcam, Cambridge, UK, monoclonal mouse antihuman clone NAT105, RRID:AB_881954), TIGIT (Cell Signaling Technology, Danvers, MA, USA; monoclonal rabbit anti-human clone ESY1W, RRID:AB_2922806), Tim-3 (Bio-Techne, Minneaoplis, MN, USA, polyclonal goat anti-human, RRID:AB_355235), Lag3 (Novus, BioTechne, monoclonal mouse anti-human clone 17B4, RRID:AB_11162489), CD94 (Diaclone, Besançon, France; monoclonal mouse anti-human clone B-D49, RRID:AB_2922808), PD-L1 Cancers 2022, 14, 4261 5 of 21 (Programmed death-ligand 1) (Cell Signaling Technology, monoclonal rabbit anti-human clone E1L3N, RRID:AB_2687655), CD155 (Cell Signaling Technology, monoclonal mouse anti-human clone D8A5G, RRID:AB_2799970), galectin-9 (Abcam, polyclonal rabbit antihuman, RRID:AB_1268942), HLA-DR (Abcam, monoclonal mouse anti-human clone SPM289, RRID:AB_444051) and HLA-E (Bio-Rad, Marnes-la-Coquette, France; monoclonal mouse anti-human clone MEM-E/02, RRID:AB_324025).

Techniques: Quantitative Proteomics, Generated, MANN-WHITNEY